Clinical Trials on Glabellar Crease
Total 10000 results
-
Fudan UniversityRecruiting
-
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.Active, not recruiting
-
Seagen, a wholly owned subsidiary of PfizerActive, not recruitingHER2-positive Breast CancerUnited States, China, Canada, United Kingdom, Belgium, Spain, Switzerland, Australia, Singapore, Japan, France, Denmark, Netherlands, Sweden, Taiwan, Germany, Austria, Israel, Italy, South Korea
-
University of Texas Southwestern Medical CenterCancer Prevention Research Institute of TexasCompletedBreast Cancer FemaleUnited States
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityActive, not recruitingMetastatic Breast Cancer | HRD-Positive/HER2-Negative Advanced Breast CancerChina
-
Seoul National University HospitalActive, not recruitingBreast Cancer | HER2-positive Breast Cancer | Chemotherapy EffectSouth Korea
-
Institut Paoli-CalmettesNovartis PharmaceuticalsActive, not recruitingAdvanced or Metastatic Breast Cancer (BC)France
-
Pierre Fabre MedicamentIQVIA Pty LtdCompletedBreast Cancer | HER2-positive Breast Cancer | Adjuvant TherapySpain, France, Italy, Belgium, Croatia
-
Sichuan Baili Pharmaceutical Co., Ltd.Baili-Bio (Chengdu) Pharmaceutical Co., Ltd.Active, not recruitingHER2-positive Breast CancerChina
-
The First Hospital of Jilin UniversityEnrolling by invitationBreast Cancer Metastatic | Efficacy and SafetyChina
-
Genor Biopharma Co., Ltd.CompletedLocally Advanced or Metastatic Breast CancerChina
-
Taiho Oncology, Inc.CompletedAdvanced Solid Tumors (Excluding Breast Cancer)United States
-
Universidad de La FronteraCompletedResistance Training | Postmenopause | Breast Cancer SurvivorsChile
-
Istanbul Aydın UniversityActive, not recruiting
-
Yale UniversityCompletedBreast NeoplasmsUnited States
-
University of OviedoCompletedWomen's Health: Neoplasm of BreastSpain
-
Cancer Institute and Hospital, Chinese Academy...UnknownHormone Receptor Positive Advanced Breast CancerChina
-
West German Study GroupSanofi; AmgenCompletedPrimary Breast Cancer | Her2 Non-overexpressingGermany
-
CancerCare ManitobaTerminatedBody Image Disturbance | Breast Cancer FemaleCanada
-
Xijing HospitalUnknown
-
Eisai Korea Inc.CompletedLocally Advanced or Metastatic Breast CancerKorea, Republic of
-
R-PharmGlaxoSmithKlineTerminatedLocally Advanced or Metastatic Breast CancerUnited States, Italy, Australia
-
Instituto do Cancer do Estado de São PauloFundação Faculdade de MedicinaTerminatedLocally Advanced HER2-negative Breast CancerBrazil
-
Instituto do Cancer do Estado de São PauloFundação Faculdade de MedicinaTerminatedLocally Advanced HER2-positive Breast CancerBrazil
-
National Cancer Institute, ThailandCompleted
-
Pomeranian Medical University SzczecinMaria Sklodowska-Curie National Research Institute of Oncology; Regional Oncology...UnknownBRCA1 Mutation | Breast Cancer Invasive NosPoland
-
Jiangsu Cancer Institute & HospitalRecruiting
-
Fudan UniversityRecruitingTNBC - Triple-Negative Breast CancerChina
-
The First Affiliated Hospital with Nanjing Medical...Not yet recruitingTNBC, Triple Negative Breast CancerChina
-
Massachusetts General HospitalNational Cancer Institute (NCI)Not yet recruitingTriple Negative Breast Cancer (TNBC)United States
-
Mario Negri Institute for Pharmacological ResearchIRCCS San Raffaele; Fondazione IRCCS Istituto Nazionale dei Tumori, Milano; Papa... and other collaboratorsNot yet recruitingBreast Cancer | Neoadjuvant Therapy | HR Positive | HER2 + Breast CancerItaly
-
Cancer Institute and Hospital, Chinese Academy...Not yet recruiting
-
The First Affiliated Hospital with Nanjing Medical...RecruitingTriple Negative Breast Cancer (TNBC)China
-
Henan Cancer HospitalNot yet recruiting
-
University College London HospitalsUniversity of West LondonRecruitingBreast Cancer Early Stage Breast Cancer (Stage 1-3)United Kingdom
-
Harbin Medical UniversityNot yet recruiting
-
Institut Investigacio Sanitaria Pere VirgiliRecruitingBreast Cancer Females | Telomere LengthSpain
-
Fudan UniversityRecruiting
-
University of Eastern PiedmontRecruiting
-
Novartis PharmaceuticalsRecruitingHR+/HER2- Early Breast CancerSaudi Arabia
-
Samsung Medical CenterPusan National University Yangsan HospitalRecruitingBreast Cancer | Digital Health | Breast Cancer SurvivorshipKorea, Republic of
-
Fujian Medical UniversityNot yet recruitingHR+/HER2- Advanced Breast Cancer
-
Henan Cancer HospitalNot yet recruitingHER2-positive, Metastatic Breast Cancer
-
Center Eugene MarquisRecruitingBreast Cancer Female | Localized CancerFrance
-
Jazz PharmaceuticalsRecruitingMetastatic HER2-positive Breast CancerUnited States, Austria, Italy, Spain, France, United Kingdom, Japan, Germany, Belgium, Greece, Australia, Canada, Poland, Brazil, South Korea
-
Shandong Suncadia Medicine Co., Ltd.RecruitingUnresectable or Metastatic Breast CancerChina
-
Tianjin Medical University Cancer Institute and...Recruiting
-
Shengjing HospitalRecruitingStage II-III Breast CancerChina
-
Deborah Farr, MDRecruitingBreast Cancer | High Risk of Breast CancerUnited States
-
Kind Pharmaceuticals LLCRecruitingAdvanced or Metastatic Breast CancerUnited States